Home
Conditions
Penile Neoplasms

Clinical trial condition

Penile Neoplasms

Explore clinical trials studying Penile Neoplasms. Study availability and eligibility vary by location and protocol.

82 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Penile Neoplasms trial results

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions: Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States

View all 582 locations

View Trial Details

Recruiting

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

NCT04923178

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +25 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Integrated Cancer Repository for Cancer Research

NCT02012699

Conditions: Abdominal Neoplasms, Adenoma, Adenomatous Polyposis Coli, +195 more
Locations: Advent Health Greenwood Village, Colorado, United States

Hartford HealthCare Cancer Institute at Manchester Medical Hospital Manchester, Connecticut, United States

Florida Hospital Memorial Medical Center Daytona Beach, Florida, United States

Florida Hospital DeLand DeLand, Florida, United States

View all 42 locations

View Trial Details

Recruiting

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

NCT05639972

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +54 more
Locations: Rutgers Cancer Institute New Brunswick, New Jersey, United States

RWJBarnabas Health - Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States

View Trial Details

Recruiting

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

NCT05686226

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +62 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

Rutgers Cancer Institute New Brunswick, New Jersey, United States

RWJBarnabas Health - Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States

View Trial Details

Recruiting

Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis

NCT06104618

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

QL1706 Plus Lenvatinib in Previously Treated Penile Cancer

NCT07384416

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

DEfeating PEnile CAncer-2

NCT07378670

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Charité- Universitätsmedizin Berlin Berlin, Germany

University Hospital Carl Gustav Carus Dresden, Germany

Universitätsklinikum Erlangen Erlangen, Germany

University Medical Center of Johannes Gutenberg-University Mainz, Germany

View Trial Details

Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations: Hospital São Carlos Fortaleza, Ceará, Brazil

Hospital São Rafael Salvador, Estado de Bahia, Brazil

Hospital Santa Cruz Curitiba, Paraná, Brazil

IDOR Recife Recife, Pernambuco, Brazil

View Trial Details

Recruiting

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma

NCT07054307

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Penile Neoplasms

Penile Neoplasms trial results

Related conditions